Condensed Consolidated Statements of Income (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenues (premium equivalents of $98,896 and $76,977 for the three months ended June 30, 2017 and 2016, respectively and $189,836 and $147,717 for the six months ended June 30, 2016, respectively)	$ 61,783	$ 44,494	$ 117,651	$ 86,984
Operating expenses:
Third-party commissions	35,108	25,859	66,543	51,849
Credit card and ACH fees	1,232	974	2,415	1,857
Selling, general and administrative	14,697	11,697	29,954	23,667
Depreciation and amortization	992	797	1,930	1,532
Total operating expenses	52,029	39,327	100,842	78,905
Income from operations	9,754	5,167	16,809	8,079
Other expense:
Interest expense	1	100	0	155
Tax Receivable Agreement expense	0	244	0	429
Fair value adjustment to contingent acquisition consideration	0	15	0	15
Other expense	1	1	4	3
Net income before income taxes	9,752	4,807	16,805	7,477
Provision for income taxes	2,800	537	1,331	921
Net income	6,952	4,270	15,474	6,556
Net income attributable to noncontrolling interests	2,569	2,413	5,257	3,794
Net income attributable to Health Insurance Innovations, Inc.	$ 4,383	$ 1,857	$ 10,217	$ 2,762
Net income per share attributable to Health Insurance Innovations, Inc.
Basic (in USD per share)	$ 0.38	$ 0.24	$ 1.00	$ 0.36
Diluted (in USD per share)	$ 0.35	$ 0.24	$ 0.91	$ 0.36
Weighted average Class A common shares outstanding
Basic (in shares)	11,550,204	7,592,972	10,228,564	7,578,264
Diluted (in shares)	12,365,914	7,732,664	11,220,687	7,716,202